Related references
Note: Only part of the references are listed.Hepatitis C: The End of the Beginning and Possibly the Beginning of the End
Harvey J. Alter et al.
ANNALS OF INTERNAL MEDICINE (2012)
Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection
Jason Grebely et al.
HEPATOLOGY (2012)
Naturally Occurring Antibodies That Recognize Linear Epitopes in the Amino Terminus of the Hepatitis C Virus E2 Protein Confer Noninterfering, Additive Neutralization
Alexander W. Tarr et al.
JOURNAL OF VIROLOGY (2012)
Structural Basis for Broad Neutralization of Hepatitis C Virus Quasispecies
Pascal Lapierre et al.
PLOS ONE (2011)
Meta-Analysis of Hepatitis C Virus Vaccine Efficacy in Chimpanzees Indicates an Importance for Structural Proteins
Harel Dahari et al.
GASTROENTEROLOGY (2010)
Characterization of Antibodies Induced by Vaccination with Hepatitis C Virus Envelope Glycoproteins
Ranjit Ray et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Hepatitis C virus with a naturally occurring single amino-acid substitution in the E2 envelope protein escapes neutralization by naturally-induced and vaccine-induced antibodies
Hongying Duan et al.
VACCINE (2010)
Selection Pressure From Neutralizing Antibodies Drives Sequence Evolution During Acute Infection With Hepatitis C Virus
Kimberly A. Dowd et al.
GASTROENTEROLOGY (2009)
Diagnosis, Management, and Treatment of Hepatitis C: An Update
Marc G. Ghany et al.
HEPATOLOGY (2009)
The global burden of hepatitis C
Daniel Lavanchy
LIVER INTERNATIONAL (2009)
Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity
Pei Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation
I. Zubkova et al.
VACCINE (2009)
High Incidence of Hepatitis C Virus Reinfection in a Cohort of Injecting Drug Users
Campbell Kynoch Aitken et al.
HEPATOLOGY (2008)
Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain
Jens Bukh et al.
JOURNAL OF VIROLOGY (2008)
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge
Mansun Law et al.
NATURE MEDICINE (2008)
Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma
Pei Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C
Jan M. Pestka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry
Heidi E. Drummer et al.
JOURNAL OF VIROLOGY (2006)
Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee
JW Youn et al.
HEPATOLOGY (2005)
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes
P Simmonds et al.
HEPATOLOGY (2005)
Adaptive immune responses in acute and chronic hepatitis C virus infection
DG Bowen et al.
NATURE (2005)
Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection
M Puig et al.
VACCINE (2004)
Neutralizing antibody response during acute and chronic hepatitis C virus infection
C Logvinoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cell-mediated immunity and the outcome of hepatitis C virus infection
NH Shoukry et al.
ANNUAL REVIEW OF MICROBIOLOGY (2004)
Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma
MYW Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
HCV persistence and immune evasion in the absence of memory T cell help
A Grakoui et al.
SCIENCE (2003)
Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees
M Nascimbeni et al.
JOURNAL OF VIROLOGY (2003)
Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81
HE Drummer et al.
JOURNAL OF VIROLOGY (2002)
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs
R Burioni et al.
VIROLOGY (2001)
Share Paper
